Company: BLCO
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001860742-25-000023
Chunk: 15

Company: Bausch & Lomb Corp
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 8
Chunk 15
---
960 Payments and credits(316)(56)(823)(479)(46)(1,720)Reserve balance, September 30, 2024$140 $84 $449 $56 $29 $758 Included in Rebates in the table above are cooperative advertising credits due to customers of approximately $38 million and $35 million as of September 30, 2024 and January 1, 2024, respectively, which are reflected as a reduction of Trade receivables, net in the Condensed Consolidated Balance Sheets.  For the nine months ended September 30, 2024, included in Payments and credits in the table above, are payments made, or to be made, by Novartis, on behalf of the Company, in accordance with the agreements associated with the XIIDRA Acquisition in September 2023.Contract Assets and Contract LiabilitiesThere are no contract assets for any period presented. Contract liabilities consist of deferred revenue, the balance of which is not material to any period presented.Allowance for Credit LossesAn allowance is maintained for potential credit losses. The Company estimates the current expected credit loss on its receivables based on various factors, including historical credit loss experience, customer credit worthiness, value of collaterals (if any), and any relevant current and reasonably supportable future economic factors. Additionally, the Company generally estimates the expected credit loss on a pooled basis when customers are deemed to have similar risk characteristics. Trade receivable balances are written off against the allowance when it is deemed probable that the trade receivable will not be collected. Trade receivables, net are stated net of certain sales provisions and the allowance for credit losses.The activity in the allowance for credit losses for trade receivables for the nine months ended September 30, 2025 and 2024 is as follows:Nine Months EndedSeptember 30,(in millions)20252024Balance, beginning of period$18 $21 Provision5 2 Write-offs(7)(3)Foreign exchange and other1 (1)Balance, end of period$17 $19 

9

4.RELATED PARTIESPrior to May 10, 2022, Bausch + Lomb had been managed and operated in the ordinary course of business with other affiliates of BHC. On May 10, 2022, Bausch + Lomb became an independent publicly traded company. As of October 22, 2025, BHC directly or